ahlam1399
08-31-2016, 03:50 PM
**vartis bid to sell new biosimilar crimped by U.S. court battles
ZURICH (Reuters) - **vartis has won U.S. approval for a copy of Amgen's blockbuster arthritis drug Enbrel, but the Swiss drugmaker's bid to muscle in on the medicine's $4.7 billion in annual U.S. revenue remains blocked by court battles.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=aSuSSVoEexU:C9D-55miXHg:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aSuSSVoEexU:C9D-55miXHg:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=aSuSSVoEexU:C9D-55miXHg:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aSuSSVoEexU:C9D-55miXHg:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=aSuSSVoEexU:C9D-55miXHg:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/aSuSSVoEexU
ZURICH (Reuters) - **vartis has won U.S. approval for a copy of Amgen's blockbuster arthritis drug Enbrel, but the Swiss drugmaker's bid to muscle in on the medicine's $4.7 billion in annual U.S. revenue remains blocked by court battles.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=aSuSSVoEexU:C9D-55miXHg:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aSuSSVoEexU:C9D-55miXHg:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=aSuSSVoEexU:C9D-55miXHg:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aSuSSVoEexU:C9D-55miXHg:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=aSuSSVoEexU:C9D-55miXHg:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/aSuSSVoEexU